Ambee Square Aci Beacon IBNSINA Marico Pharm Orion Beximc GSK

Pharma pharma Aid Infusion o

Pharma
200 201 200 201 200 201 200 201 200 201 200 201 200 201 200 201 200 201 200 201
9 5 9 5 9 5 9 5 9 5 9 5 9 5 9 5 9 5 9 5
Profitability
Return on capital 0.83 24.8
0.11 0.06 0.08 18.7 0.18 0.37
employed % 0.17 0% 0.25 0.30 0.51 0.40
33 68 14 4 57 692
(ROCE)
Return on Assets 0.01 0.04 1.34 41.4 0.10 0.15 0.10
(ROA) 38.3 0.11 0.15
53 351 % 0% 7 4 7
Gross margin 52.3 44.0 0.32 31.1 0.53 48.2 40.0 46.4 38.3 39.4
0.27 11.6 0.45 0.45 0.37
8% 0% 72 8% 96 9% 3% 5% 9% 0%
Liquidity
Current ratio 2.28
7.29
.96 1.05 1.46 3.82 1.28 0.81 2.62 2.33 0.81 27 1.6 1.19 1.63 0.53 2.97 1.78 3.10 1.72
588
Quick ratio 1.32
0.90 1.06 2.43 0.99
0.57 2.52 0.42 1.22 0.47 3 0.47 1.42 0.39 0.95 1.25 1.68 1.39
2 8 16 6
Activity
Asset turnover 1.10 0.80 1.92 1.22 0.15 0.44 6.49 2.25 2.02 0.81 0.92
0.18 0.54 0.53 5.62 2.92
85 57 1 78 176 01 14 02 57 4 33
Inventory days 180.
282. 73.8 118. 391. 151. 31.8 131. 49.6 76.9
151 134 84 41 244 150 107 70
931 552 78 78 38 307 30 99 7
Risk
Capital gearing
(leverage) 1.63 0.04 0.37 0.02
6.35 1.13 5.15 1.63 1.94 1.96 1.61 3.84
01 7 53 26
 Objective 1 Objective 2 Objective 3 Objective 4
Profitability Sales growth Customer retention and Employee retention and
satisfaction satisfaction

Customer perspective Financial perspective Internal business perspective Learning and growth
perspective
Retention of RONA Out of stock Employee
customers rate retention

Revenue Sales growth Accuracy in Employee

from delivery suggestions
value-added order
partnerships